Replies to post #164660 on Cytodyn Inc (CYDY)

[misiu143]

" And the patients who have elevated GM-CSF are the exact patients who go to be severe and die "

Good , so why leronlimab , a CCR5 inhibitor is taking patients off ECMO , and lenzilumab is treating moderate to slightly severe ..without any other problems or infection in these patients of course...

I should go to sleep already , but your questions don't let me..:))

All IMO.